ALDX Q1 2017 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ALDXAldeyra Therapeutics, Inc.

$290M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M

Gross Profit

$4M100.0% margin

Operating Income

-$5M-127.0% margin

Net Income

-$5M-126.9% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

-75.1%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$858,096

Balance Sheet

Total Assets

$32M

Total Liabilities

$4M

Stockholders' Equity

$28M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$0	—
Gross Profit	$4M	$0	—
Operating Income	-$5M	-$5M	-2.6%
Net Income	-$5M	-$5M	-2.5%